Beyond the COA: How Analytical Testing Labs Detect Adulteration in Botanical Raw Materials

The FDA’s tainted dietary supplements database has catalogued more than 900 products containing undeclared pharmaceutical ingredients — stimulants, prescription weight-loss drugs, erectile dysfunction medications, and controlled anabolic agents — the majority of them sold as “all-natural” herbal formulas. Most of those enforcement actions trace back to the same failure point: a brand that trusted a supplier’s COA without independent verification.

If you source botanical raw materials at any scale, you know the COAs. They arrive on letterhead, stamped with accreditation logos, listing heavy metals results, microbial counts, and identity confirmations. Some of them are legitimate. Some are not. And even the legitimate ones often miss exactly what you need to know.

That’s where independent analytical testing labs enter — not as a regulatory formality, but as the only credible mechanism for confirming that what’s on a label actually matches what’s in the material.

The COA Problem Nobody Wants to Talk About

Under 21 CFR Part 111 — the FDA’s current good manufacturing practice regulations for dietary supplements — brand owners are required to verify the identity of every incoming raw material. That verification cannot simply be a supplier’s COA, no matter how polished it looks. Section 111.75 specifically requires that you conduct at least one appropriate test or examination to verify each specification. Relying solely on a supplier’s certificate of analysis is a Form 483 observation waiting to happen.

But the compliance gap is only part of the story. The global herbal ingredient supply chain is complex enough that adulteration, substitution, and dilution happen at multiple tiers — not always from dishonest suppliers, but sometimes from well-meaning ones who themselves received misidentified or substandard material upstream. Economically motivated adulteration (EMA), as the FDA and USP have formally categorized it, is especially prevalent in high-value botanicals where cheaper fillers blend invisibly with the genuine material.

A 2013 study published in BMC Medicine (Newmaster et al.) tested 44 herbal products from 12 companies using DNA barcoding and found adulteration in more than 59% of the products examined. That figure is routinely debated in the industry — DNA barcoding has real limitations with heavily processed extracts — but even discounting it significantly, the failure rate is too high for any quality program to absorb without independent testing.

The COA tells you what one lab found in one sample at one point in time. An independent analytical testing lab tells you what’s actually in the material you’re about to put into your product.

What Analytical Testing Actually Uncovers

The gap between what a supplier’s COA reports and what qualified analytical testing labs find tends to fall into a few predictable categories.

Wrong species, right genus. This is one of the most common findings in botanical verification. A supplier ships what’s labeled as Echinacea purpurea but the material contains Echinacea angustifolia, Echinacea pallida, or in some cases a different genus entirely. To the naked eye, the powders are indistinguishable. Many basic chromatography methods won’t catch the substitution. High-Performance Thin-Layer Chromatography (HPTLC) run against authenticated reference standards — combined with DNA barcoding for unprocessed materials — is currently the most defensible combination for species-level identification.

Dilution with fillers. Expensive botanicals like turmeric, saffron, valerian, and holy basil are routinely extended with cheaper materials — rice flour, maltodextrin, starch, or lower-grade plant parts. A qualified lab catches this through HPTLC fingerprinting, near-infrared spectroscopy, and marker compound quantification. If a turmeric extract is labelled at ≥95% curcuminoids and third-party testing returns 68%, that’s not measurement variability. That’s dilution.

Undeclared synthetic compounds. This is where the risk becomes serious. FDA warning letters in recent years have identified herbal products containing sildenafil or tadalafil analogs (in sexual enhancement formulas), sibutramine and phenolphthalein (in weight management botanicals), and undeclared stimulants like DMAA in “energy” blends. Standard HPTLC identity panels won’t catch these. Detecting undeclared pharmaceuticals requires targeted screening — LC-MS/MS, high-resolution mass spectrometry (HRMS), or NMR in specific cases. Analytical testing labs equipped for adulteration screening run these methods in addition to standard identity panels, not instead of them.

Elemental contamination above specification. Lead, arsenic, cadmium, and mercury in botanical raw materials remain persistent challenges, particularly for ingredients sourced from regions with industrial soil contamination. USP <232> and <233> establish permitted daily exposure (PDE) limits for 24 elemental impurities. ICP-MS reliably quantifies these elements at concentrations below 1 ppb. COAs that report heavy metals using older colorimetric or atomic absorption methods may show specification conformance while actually exceeding USP <232> limits — a mismatch that creates real compliance exposure downstream.

The Methods That Make the Difference

Not every analytical testing lab offers the same depth of testing. Understanding the method hierarchy helps you ask the right questions of your contract lab before you’re in a crisis.

HPTLC fingerprinting against authenticated reference standards — from USP, the American Botanical Council, or the HPTLC Association — is the baseline for botanical identity under USP <2021>. A proper HPTLC test produces a visual fingerprint comparing your material against a verified reference, with peaks, bands, and Rf values that either match or they don’t. It’s not infallible with complex or heavily processed extracts, but it remains the most practical, cost-effective first-line identity method in current use.

DNA barcoding and metabarcoding provide a complementary authentication layer, particularly for raw, minimally processed plant materials. The FDA has invested substantially in botanical DNA method development, and USP has incorporated DNA-based testing into several botanical monographs. One important caveat: extensive processing — hydrolysis, high-heat drying, acid extraction — can degrade DNA to the point where amplification fails. A negative DNA result doesn’t necessarily mean absence of the target species in a processed extract. It means the DNA signal is unreadable.

LC-MS/MS for adulteration screening is where most brands underinvest. Standard identity testing tells you what’s present; targeted LC-MS/MS panels tell you what shouldn’t be there. Established screening panels now cover hundreds of pharmaceutical adulterants across common botanical categories — weight management, sexual enhancement, sports performance, and cognitive support. If you’re sourcing material in any of these categories without running an adulteration screen, you’re carrying risk that your COA simply cannot quantify.

ICP-MS for elemental impurities under USP <232>/<233> is non-negotiable for any botanical intended for finished supplement use. The 24 impurities covered include Class 1 elements — arsenic, cadmium, mercury, lead — with hard oral PDE limits regardless of source or processing. ICP-MS routinely achieves detection limits at sub-ppb levels, far below the sensitivity floor of older analytical methods.

Building a Supplier Qualification Program That Holds Up to Scrutiny

The question most brand owners ask is whether they need to test every lot from every supplier, every time. The practical answer depends on documented qualification data — and on your risk assessment.

Under 21 CFR Part 111, you can reduce testing frequency for a supplier with a documented compliance history. But you can only establish that history through a statistically valid sampling program: testing every lot during a qualification period (typically six to twelve months, or a defined lot count), building a specification conformance dataset, and documenting your decision to reduce sampling frequency in your quality system.

For high-risk ingredients — botanicals with known EMA histories, materials from new or unaudited suppliers, or any category that’s drawn recent FDA enforcement activity — maintaining elevated testing frequency is the defensible position. A contaminated lot entering production, or worse, a finished product recall, will cost multiples of any savings achieved through reduced sampling.

Three practical steps that consistently make the difference:

1. Require suppliers to disclose their testing methodology, not just their results. A COA that says “identity: conforms” without specifying the method — HPTLC, organoleptic, microscopy — provides almost no meaningful information. Ask for the method, the reference standard used, and the analyst’s qualification.

2. Use independent analytical testing labs for at minimum identity and adulteration verification, even if your internal lab handles microbiology and routine chemistry. External verification removes the financial conflict of interest inherent in any in-house supplier testing relationship.

3. Cross-reference your contract lab results against the supplier COA systematically over time. Discrepancies — even minor ones, like marker compound values that are technically within spec but trending lower across consecutive lots — are early warning signs worth investigating before they become a quality event or an FDA action.

The brands that consistently avoid adulteration-related recalls and warning letters aren’t the ones with the most sophisticated internal quality teams. They’re the ones with disciplined, documented external verification at every critical control point in the supply chain.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025-Accredited Raw Material & Supplement Testing — Qalitex Laboratories performs HPTLC identity, ICP-MS elemental analysis, and LC-MS/MS adulteration screening under ISO 17025 accreditation for brands nationwide.